Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population With Type 1 or Type 2 Diabetes: The CAN-TREAT Study
mediaposted on 29.04.2021, 08:38 by Adis journals on behalf of, Stewart B. Harris, Olubukola Ajala, Basel Bari, Joanne Liutkus, Jina Hahn, Oliver Martyn, Deborah Zwicker
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.